Clinical trial
The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection
NCT06049771 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection
- Lead sponsor
- Phramongkutklao College of Medicine and Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 17, 2023
- Completion date
- June 30, 2025
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae